Literature DB >> 1772125

Case report: disseminated Mycobacterium gordonae infection in a nonimmunocompromised host.

L N Jarikre1.   

Abstract

Mycobacterium gordonae is considered the least pathogenic of the Runyon Group II mycobacteria, although there are now well-documented reports of infection varying from localized soft tissue infection to disseminated life threatening diseases. We report a 40-year-old Pakistani housewife, treated in childhood for tuberculosis, who presented with severe systemic illness, fever, ascites, hepatomegaly, persistent dysuria with sterile pyuria, pulmonary disease, and anorexia with weight loss. Liver biopsy histology showed multiple granulomata and multiple isolation of M. gordonae from sputum and urine, in keeping with disseminated mycobacterial infection. She had dramatic response to antituberculosis therapy with streptomycin, isoniazid, rifampicin, and pyrazinamide. No evidence existed for disturbed humoral or cellular immunity and HIV infection. This represents the fifth reported case of disseminated M. gordonae infection, the first from the Arabian Gulf. It was treated successfully with standard antituberculosis regimen.

Entities:  

Mesh:

Year:  1991        PMID: 1772125     DOI: 10.1097/00000441-199112000-00012

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  3 in total

1.  Bactericidal, virucidal, and mycobactericidal activities of reused alkaline glutaraldehyde in an endoscopy unit.

Authors:  J N Mbithi; V S Springthorpe; S A Sattar; M Pacquette
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

2.  Prevalence and diversity of Chlamydiales and other amoeba-resisting bacteria in domestic drinking water systems.

Authors:  J Lienard; A Croxatto; A Gervaix; Y Lévi; J-F Loret; K M Posfay-Barbe; G Greub
Journal:  New Microbes New Infect       Date:  2016-11-14

Review 3.  Nontuberculous Mycobacteria in Saudi Arabia and Gulf Countries: A Review.

Authors:  Hawra Al-Ghafli; Sahal Al-Hajoj
Journal:  Can Respir J       Date:  2017-02-27       Impact factor: 2.409

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.